Laughter and Therapy Could Go a Long Way for the Heart

The session was entitled “Don’t worry, be happy,” but the research had a serious side to it, stressing that anger and job stress are linked to higher cardiovascular event rates, while laughter and cognitive behavior therapy can lower the risk. Heartwire

Deaths From Prescription Opioids on the Rise

Deaths from opioids prescribed for noncancer pain tripled in the United States between 1999 and 2007 and are increasing in other countries, including the United Kingdom. Medscape Medical News

Exercise in Early Adulthood Improves Fitness Later

Higher scores on physical performance measures are seen among those with higher levels of activity earlier in life. Medscape Medical News

Teen Pregnancy and Reproductive Health

Make it easy for young men and women to discuss sexual health and reproductive issues with you. CDC Expert Commentary

Drug Study Endpoints Called into Question (CME/CE)

(MedPage Today) — An increasing number of drug studies use surrogate and composite endpoints, as well as disease-specific rather than all-cause mortality, researchers said.

Bird Flu Back Again, U.N. Agency Warns

(MedPage Today) — A new vaccine-resistant strain of avian H5N1 influenza has begun circulating in poultry flocks in Vietnam and China, posing “unpredictable risks to human health,” the Food and Agriculture Organization warned on Monday.

Breast Implant Safety to Be Focus of FDA Panel

WASHINGTON (MedPage Today) — An FDA advisory committee is holding a two-day meeting this week to discuss how the agency can better track the safety and efficacy of silicone gel-filled breast implants years after a woman has received them.

Breast Implant Safety to Be Focus of FDA Panel

WASHINGTON (MedPage Today) — An FDA advisory committee is holding a two-day meeting this week to discuss how the agency can better track the safety and efficacy of silicone gel-filled breast implants years after a woman has received them.

FDA Denies Biologic for Gout

(MedPage Today) — The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug’s manufacturer said.

Results of Aeterna Zentaris’ AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.